Aiymkul Ashimkhanova
Overview
Explore the profile of Aiymkul Ashimkhanova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mussina K, Abbay A, Sakko Y, Syssoyev D, Gusmanov A, Abdrakhmanova A, et al.
Front Public Health
. 2023 Jul;
11:1138604.
PMID: 37408741
Background And Objectives: Although global HIV pandemic has stabilized, it continues to rise in Eastern Europe and Central Asia due to exponential growth of newly acquired cases. Based on UNAIDS,...
2.
Akhatova A, Azizan A, Atageldiyeva K, Ashimkhanova A, Marat A, Iztleuov Y, et al.
Vaccines (Basel)
. 2022 Nov;
10(11).
PMID: 36423008
Immunization is the most successful method in preventing and controlling infectious diseases, which has helped saving millions of lives worldwide. The discovery of the human papillomavirus (HPV) infection being associated...
3.
Ashimkhanova A, Syssoyev D, Gusmanov A, Yesmembetov K, Yespotayeva A, Abbay A, et al.
Infect Drug Resist
. 2022 Jul;
15:3333-3346.
PMID: 35782528
Background: Viral hepatitis is the leading cause of hepatic cirrhosis and liver-related mortality, yet there are no countrywide epidemiological studies available to date in Kazakhstan. The aim of the study...
4.
Seroprevalence and risk factors for hepatitis B and hepatitis C in three large regions of Kazakhstan
Nersesov A, Gusmanov A, Crape B, Junusbekova G, Berkinbayev S, Jumabayeva A, et al.
PLoS One
. 2021 Dec;
16(12):e0261155.
PMID: 34914773
Background & Aims: Kazakhstan has implemented comprehensive programs to reduce the incidence of Hepatitis B and Hepatitis C. This study aims to assess seroprevalence and risk factors for HBsAg and...
5.
Coelho T, Sonnenberg-Riethmacher E, Gao Y, Mossotto E, Khojanazarov A, Griffin A, et al.
Sci Rep
. 2021 Mar;
11(1):6194.
PMID: 33737520
The precise role of periostin, an extra-cellular matrix protein, in inflammatory bowel disease (IBD) is unclear. Here, we investigated periostin in paediatric IBD including its relationship with disease activity, clinical...
6.
Abdrakhman A, Ashimkhanova A, Almawi W
Antiviral Res
. 2020 Dec;
185:104995.
PMID: 33321155
Chronic HDV infection often is associated with aggressive form of liver disease, compared to chronic HBV mono-infection. However, chronic HDV treatment is challenging because currently there is no approved regimen...
7.
Vento S, Cainelli F, Ashimkhanova A
Lancet Gastroenterol Hepatol
. 2017 Apr;
1(1):8-9.
PMID: 28404117
No abstract available.
8.
Chen Y, Shen C, Guha D, Ding M, Kulich S, Ashimkhanova A, et al.
BMC Infect Dis
. 2016 Nov;
16(1):693.
PMID: 27875997
Background: Infection with human immunodeficiency virus (HIV) influences the outcome and natural disease progression of hepatitis C virus (HCV) infection. While the majority of HCV mono-infected and HCV/HIV co-infected subjects...
9.
Yesmembetov K, Ashimkhanova A, Kaliaskarova K
Exp Clin Transplant
. 2016 Nov;
14(Suppl 3):112-113.
PMID: 27805527
A 40-year-old man, diagnosed with decompensated liver cirrhosis because of hepatitis C virus, was on the wait list for a liver transplant when he began treatment with the direct-acting antivirals...
10.
Sultanaliev T, Zhexembayev A, Mukazhanov A, Zharkymbekov B, Kuttymuratov G, Spatayev Z, et al.
Exp Clin Transplant
. 2015 Dec;
13 Suppl 3:120-2.
PMID: 26640930
Objectives: Kazakhstan is experiencing a high demand for liver transplants. More than 1000 patients have end-stage liver disease in the country, and liver transplant is the only viable option for...